Answer
It is preferable to avoid Holoclar during pregnancy as a precaution and because postoperative pharmacological treatment is required, with no data available in pregnant women or animal reproductive-toxicity studies.
Sources for this answer
- Holoclar 79,000 - 316,000 cells/cm2 living tissue equivalentHolostem s.r.l · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked